The latest news in renal cancer
ASCO GU 2025: Some kidney cancer patients can stop combination treatment after two years
A new study presented today by researchers at Fox Chase Cancer Center shows that some…
Browsing: Kidney Cancer
Cancer vaccine shows promise for patients with stage III and IV kidney cancer
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for…
Phase 2 LITESPARK-003 results suggest continued study of novel first-line combo for advanced kidney cancer
RESEARCH SUMMARY Study Title: Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal…
Predicting how childhood kidney cancers develop
Genetically tailored treatment plans for children with a type of kidney cancer could help provide…
Even low levels of arsenic in drinking water raise kidney cancer risk
New research findings from the Texas A&M University School of Public Health, USA, indicate that…
Biomarker may predict immunotherapy response in liver cancer
It may soon be possible to determine which patients with a type of liver cancer…
New imaging technique accurately detects aggressive kidney cancer
A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Centre, USA, has demonstrated…
Graph filtration learning reveals new dimensions in hepatocellular carcinoma imaging
A new editorial was published in Oncotarget’s Volume 15 on July 24, 2024, entitled, “Beyond pixels: Graph filtration…
Pivotal study supports belzutifan approval for patients with advanced kidney cancer
The LITESPARK-005 phase 3 clinical trial enrolled 746 patients with metastatic clear cell renal cell…
Hereditary leiomyomatosis and renal cell cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have received an $800,000 grant from the V…